Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Infective endocarditis in Western Norway: a 20-year retrospective survey.

Jordal S, Kittang BR, Salminen PR, Eide GE, Kommedal Ø, Wendelbo Ø, Haaverstad R, Sjursen H.

Infect Dis (Lond). 2018 Oct;50(10):757-763. doi: 10.1080/23744235.2018.1482419. Epub 2018 Jun 19.

PMID:
29916753
2.

Effect of Oseltamivir (Tamiflu®) for the Prevention and Treatment of Influenza During an Influenza Pandemic [Internet].

Mørland B, Brantsæter AB, Fuglesang JE, Haaheim LR, Løvoll Ø, Salmén R, Sjursen H, Kristiansen IS, Wisløff T, Ørjasæter Elvsaas IK, Nilsen E.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005.

3.

Immune responses after live attenuated influenza vaccination.

Mohn KG, Smith I, Sjursen H, Cox RJ.

Hum Vaccin Immunother. 2018 Mar 4;14(3):571-578. doi: 10.1080/21645515.2017.1377376. Epub 2018 Jan 3. Review.

4.

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model.

Jacobsen H, Rajendran M, Choi A, Sjursen H, Brokstad KA, Cox RJ, Palese P, Krammer F, Nachbagauer R.

MBio. 2017 Sep 19;8(5). pii: e01463-17. doi: 10.1128/mBio.01463-17.

5.

Reply to Drs. Karakonstantis and Kalemaki.

Naess A, Eide GE, Sjursen H.

Infection. 2018 Apr;46(2):279-280. doi: 10.1007/s15010-017-1066-4. Epub 2017 Sep 1. No abstract available.

PMID:
28864995
6.

A man with fever and joint pain.

Lutro O, Lillebø K, Schrama JC, Dale H, Sjursen H.

Tidsskr Nor Laegeforen. 2016 Dec 20;136(23-24):1999-2001. doi: 10.4045/tidsskr.16.0266. eCollection 2016 Dec. English, Norwegian. No abstract available.

7.

Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever.

Naess A, Nilssen SS, Mo R, Eide GE, Sjursen H.

Infection. 2017 Jun;45(3):299-307. doi: 10.1007/s15010-016-0972-1. Epub 2016 Dec 19.

8.

Cardiac surgery for infective endocarditis in patients with intravenous drug use.

Østerdal OB, Salminen PR, Jordal S, Sjursen H, Wendelbo Ø, Haaverstad R.

Interact Cardiovasc Thorac Surg. 2016 May;22(5):633-40. doi: 10.1093/icvts/ivv397. Epub 2016 Jan 29.

9.

Bacterial and Hematological Findings in Infected Total Hip Arthroplasties in Norway Assessment of 278 Revisions Due to Infection in the Norwegian Arthroplasty Register.

Langvatn H, Lutro O, Dale H, Schrama JC, Hallan G, Espehaug B, Sjursen H, Engesæter LB.

Open Orthop J. 2015 Sep 30;9:445-9. doi: 10.2174/1874325001509010445. eCollection 2015.

10.

Matrix M H5N1 Vaccine Induces Cross-H5 Clade Humoral Immune Responses in a Randomized Clinical Trial and Provides Protection from Highly Pathogenic Influenza Challenge in Ferrets.

Cox RJ, Major D, Pedersen G, Pathirana RD, Hoschler K, Guilfoyle K, Roseby S, Bredholt G, Assmus J, Breakwell L, Campitelli L, Sjursen H.

PLoS One. 2015 Jul 6;10(7):e0131652. doi: 10.1371/journal.pone.0131652. eCollection 2015.

11.

Matrix M(TM) adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4(+) T cell responses in man.

Pedersen GK, Sjursen H, Nøstbakken JK, Jul-Larsen Å, Hoschler K, Cox RJ.

Hum Vaccin Immunother. 2014;10(8):2408-16. doi: 10.4161/hv.29583.

12.

Increasing Resistance of Coagulase-Negative Staphylococci in Total Hip Arthroplasty Infections: 278 THA-Revisions due to Infection Reported to the Norwegian Arthroplasty Register from 1993 to 2007.

Lutro O, Langvatn H, Dale H, Schrama JC, Hallan G, Espehaug B, Sjursen H, Engesæter LB.

Adv Orthop. 2014;2014:580359. doi: 10.1155/2014/580359. Epub 2014 Oct 9.

13.

Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans.

Nachbagauer R, Wohlbold TJ, Hirsh A, Hai R, Sjursen H, Palese P, Cox RJ, Krammer F.

J Virol. 2014 Nov;88(22):13260-8. doi: 10.1128/JVI.02133-14. Epub 2014 Sep 10.

14.

Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination.

Pedersen GK, Höschler K, Øie Solbak SM, Bredholt G, Pathirana RD, Afsar A, Breakwell L, Nøstbakken JK, Raae AJ, Brokstad KA, Sjursen H, Zambon M, Cox RJ.

Vaccine. 2014 Jul 31;32(35):4550-7. doi: 10.1016/j.vaccine.2014.06.009. Epub 2014 Jun 18.

PMID:
24950357
15.

An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans.

Krammer F, Jul-Larsen A, Margine I, Hirsh A, Sjursen H, Zambon M, Cox RJ.

Clin Vaccine Immunol. 2014 Aug;21(8):1153-63. doi: 10.1128/CVI.00272-14. Epub 2014 Jun 18.

16.

Infections in patients hospitalized for fever as related to duration and other predictors at admittance.

Naess A, Mo R, Nilssen SS, Eide GE, Sjursen H.

Infection. 2014 Jun;42(3):485-92. doi: 10.1007/s15010-013-0573-1. Epub 2013 Dec 21.

PMID:
24363209
17.

[Aminoglycosides should still be used in empirical sepsis treatment].

Lindemann PC, Haldorsen BC, Smith I, Sjursen H, Mylvaganam H.

Tidsskr Nor Laegeforen. 2013 May 28;133(10):1054-5. doi: 10.4045/tidsskr.13.0213. Norwegian. No abstract available.

18.

Should patients who use illicit drugs be offered a second heart-valve replacement?

Miljeteig I, Skrede S, Langørgen J, Haaverstad R, Jøsendal O, Sjursen H, Norheim OF.

Tidsskr Nor Laegeforen. 2013 May 7;133(9):977-80. doi: 10.4045/tidsskr.12.0779. English, Norwegian.

19.

[Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis].

Harboe E, Damås JK, Omdal R, Frøland SS, Sjursen H.

Tidsskr Nor Laegeforen. 2012 Sep 4;132(16):1867-71. doi: 10.4045/tidsskr.12.0180. Review. Norwegian.

20.

Flow cytometry technique for analysing Leishmania promastigote phagocytosis by human polymorphonuclear leucocytes and monocytes.

Rebbestad K, Herredsvela S, Sornes S, Eide GE, Müller KE, Spriet E, Sjursen H, Naess A.

Parasite Immunol. 2012 Nov;34(11):528-35. doi: 10.1111/j.1365-3024.2012.01385.x.

21.

[A man with pain following a knee operation].

Reikvam H, Power Ø, Høvding P, Lindemann PC, Sjursen H.

Tidsskr Nor Laegeforen. 2012 Jun 26;132(12-13):1472-4. doi: 10.4045/tidsskr.12.0064. Norwegian.

22.

T-helper 1 cells elicited by H5N1 vaccination predict seroprotection.

Pedersen GK, Madhun AS, Breakwell L, Hoschler K, Sjursen H, Pathirana RD, Goudsmit J, Cox RJ.

J Infect Dis. 2012 Jul 15;206(2):158-66. doi: 10.1093/infdis/jis330. Epub 2012 May 2.

PMID:
22551811
23.

Bacterial findings in infected hip joint replacements in patients with rheumatoid arthritis and osteoarthritis: a study of 318 revisions for infection reported to the norwegian arthroplasty register.

Schrama JC, Lutro O, Langvatn H, Hallan G, Espehaug B, Sjursen H, Engesaeter LB, Fevang BT.

ISRN Orthop. 2012 Oct 17;2012:437675. doi: 10.5402/2012/437675. eCollection 2012.

24.

[A slow growing bacteria].

Sjursen H.

Tidsskr Nor Laegeforen. 2011 Nov 15;131(22):2249. doi: 10.4045/tidsskr.11.0993. Norwegian. No abstract available.

25.

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial.

Cox RJ, Pedersen G, Madhun AS, Svindland S, Sævik M, Breakwell L, Hoschler K, Willemsen M, Campitelli L, Nøstbakken JK, Weverling GJ, Klap J, McCullough KC, Zambon M, Kompier R, Sjursen H.

Vaccine. 2011 Oct 19;29(45):8049-59. doi: 10.1016/j.vaccine.2011.08.042. Epub 2011 Aug 22.

PMID:
21864624
26.

Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports.

Pedersen G, Halstensen A, Sjursen H, Naess A, Kristoffersen EK, Cox RJ.

Scand J Immunol. 2011 Aug;74(2):210-8. doi: 10.1111/j.1365-3083.2011.02561.x.

27.

An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers.

Madhun AS, Akselsen PE, Sjursen H, Pedersen G, Svindland S, Nøstbakken JK, Nilsen M, Mohn K, Jul-Larsen A, Smith I, Major D, Wood J, Cox RJ.

Vaccine. 2010 Dec 16;29(2):266-73. doi: 10.1016/j.vaccine.2010.10.038. Epub 2010 Oct 27.

PMID:
21034828
28.

[Rare cause of severe disease].

Sjursen H.

Tidsskr Nor Laegeforen. 2010 Jan 28;130(2):152. doi: 10.4045/tidsskr.09.1536. Norwegian. No abstract available.

29.

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.

Cox RJ, Madhun AS, Hauge S, Sjursen H, Major D, Kuhne M, Höschler K, Saville M, Vogel FR, Barclay W, Donatelli I, Zambon M, Wood J, Haaheim LR.

Vaccine. 2009 Mar 18;27(13):1889-97. doi: 10.1016/j.vaccine.2009.01.116. Epub 2009 Feb 2.

PMID:
19368768
30.

[Toxic shock syndrome].

Sjursen H.

Tidsskr Nor Laegeforen. 2008 Dec 4;128(23):2728. Norwegian. No abstract available.

PMID:
19097314
31.

Severe malaria and artesunate treatment, Norway.

Mørch K, Strand Ø, Dunlop O, Berg A, Langeland N, Leiva RA, Longva JA, Sjursen H, Skrede S, Sundal J, Jensenius M.

Emerg Infect Dis. 2008 Nov;14(11):1816-8. doi: 10.3201/eid1411.080636. No abstract available.

32.

[Use of a new antibiotic in Norway].

Brubakk O, Bjørneklett A, Sjursen H, Viggen B.

Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1931-2. Norwegian. No abstract available.

33.

Seroprotection against diphtheria and tetanus among Russian and Norwegian teenagers.

Danilova E, Shiryayev A, Kristoffersen EK, Sjursen H.

APMIS. 2006 Jun;114(6):453-7.

PMID:
16856968
34.

Tickborne encephalitis virus, Norway and Denmark.

Skarpaas T, Golovljova I, Vene S, Ljøstad U, Sjursen H, Plyusnin A, Lundkvist A.

Emerg Infect Dis. 2006 Jul;12(7):1136-8.

35.

Antidiphtheria antibody responses in patients and carriers of Corynebacterium diphtheriae in the Arkhangelsk region of Russia.

Danilova E, Jenum PA, Skogen V, Pilnikov VF, Sjursen H.

Clin Vaccine Immunol. 2006 Jun;13(6):627-32.

36.

Attenuated immune response to tetanus toxoid in young healthy men protected against tetanus.

Danilova E, Shiryayev A, Kristoffersen EK, Sjursen H.

Vaccine. 2005 Oct 10;23(42):4980-3.

PMID:
15985319
37.

Short-term booster effect of diphtheria toxoid in initially long-term protected individuals.

Danilova E, Shiryayev A, Skogen V, Kristoffersen EK, Sjursen H.

Vaccine. 2005 Feb 10;23(12):1446-50.

PMID:
15670879
38.
39.

[Hepatitis C in Northern Norway--an 8-year material].

Kristiansen MG, Gutteberg T, Berg LK, Sjursen H, Mortensen L, Florholmen J.

Tidsskr Nor Laegeforen. 2002 Aug 30;122(20):1974-6. Norwegian.

40.

Interactions between environmental pollution and cold tolerance of soil invertebrates: a neglected field of research.

Holmstrup M, Bayley M, Sjursen H, H jer R, Bossen S, Friis K.

Cryo Letters. 2000 Sep-Oct;21(5):309-314.

PMID:
12148035
41.

Molecular characterization of Corynebacterium diphtheriae isolates, Russia, 1957-1987.

Skogen V, Cherkasova VV, Maksimova N, Marston CK, Sjursen H, Reeves MW, Olsvik Ø, Popovic T.

Emerg Infect Dis. 2002 May;8(5):516-8.

42.

Antibiotic susceptibility of blood culture isolates of Enterobacteriaceae. A Norwegian multicenter study.

Digranes A, Sjursen H, Melby KK, Solberg CO.

APMIS. 2001 Oct;109(10):641-6.

PMID:
11890566
43.

Detection of diphtheria antitoxin by four different methods.

Skogen V, Jenum PA, Koroleva VN, Danilova E, Halvorsen DS, Maksimova N, Sjursen H.

Clin Microbiol Infect. 1999 Oct;5(10):628-33. doi: 10.1111/j.1469-0691.1999.tb00420.x.

44.

[Treatment of acute bacterial meningitis].

Skrede S, Sjursen H, Solberg CO.

Tidsskr Nor Laegeforen. 2001 Nov 20;121(28):3306-9. Norwegian.

45.

[Antibiotic treatment of infectious endocarditis].

Sjursen H.

Tidsskr Nor Laegeforen. 2001 Nov 20;121(28):3300-5. Review. Norwegian.

PMID:
11826462
46.

Freeze induced glucose accumulation in the enchytraeid, Fredericia ratzeli from Greenland.

Holmstrup M, Sjursen H.

Cryo Letters. 2001 Sep-Oct;22(5):273-6.

PMID:
11788868
47.

Effects of polycyclic aromatic compounds on the drought tolerance of Folsomia fimetaria (Collembola, Isotomidae).

Sjursen H, Sverdrup LE, Krogh PH.

Environ Toxicol Chem. 2001 Dec;20(12):2899-902.

PMID:
11764177
48.

The effect of zanamivir treatment on the early immune response to influenza vaccination.

Cox RJ, Mykkeltvedt E, Sjursen H, Haaheim LR.

Vaccine. 2001 Sep 14;19(32):4743-9.

PMID:
11535325
49.

Enhanced drought tolerance of a soil-dwelling springtail by pre-acclimation to a mild drought stress.

Sjursen H, Bayley M, Holmstrup M.

J Insect Physiol. 2001 Sep;47(9):1021-1027.

PMID:
11472765

Supplemental Content

Loading ...
Support Center